Literature DB >> 12244176

IL-4 induces the proteolytic processing of mast cell STAT6.

Melanie A Sherman1, Doris R Powell, Melissa A Brown.   

Abstract

IL-4 is a potent, pleiotropic cytokine that, in general, directs cellular activation, differentiation, and rescue from apoptosis. However, in mast cells, IL-4 induces the down-regulation of activation receptors and promotes cell death. Mast cells have been shown to transduce IL-4 signals through a unique C-terminally truncated isoform of STAT6. In this study, we examine the mechanism through which STAT6 is processed to generate this isoform. We demonstrate that STAT6 processing in mast cells is initiated by IL-4-induced phosphorylation and nuclear translocation of full-length STAT6 and subsequent cleavage by a nuclear serine-family protease. The location of the protease in the nucleus ensures that the truncated STAT6 has preferential access to bind DNA. IL-4-responsive target genes in mast cells are identified by chromatin immunoprecipitation of STAT6, including the IL-4 gene itself. These results suggest a molecular explanation for the suppressive effects of IL-4 on STAT6-regulated genes in mast cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12244176     DOI: 10.4049/jimmunol.169.7.3811

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  IL-4 and TGF-beta 1 counterbalance one another while regulating mast cell homeostasis.

Authors:  Matthew R Macey; Jamie L Sturgill; Johanna K Morales; Yves T Falanga; Joshua Morales; Sarah K Norton; Nitin Yerram; Hoon Shim; Josephine Fernando; Alasdair M Gifillan; Gregorio Gomez; Lawrence Schwartz; Carole Oskeritzian; Sarah Spiegel; Daniel Conrad; John J Ryan
Journal:  J Immunol       Date:  2010-03-19       Impact factor: 5.422

Review 2.  Mast cell production and response to IL-4 and IL-13.

Authors:  Jamie J A McLeod; Bianca Baker; John J Ryan
Journal:  Cytokine       Date:  2015-06-15       Impact factor: 3.861

Review 3.  Role of STAT3 in Genesis and Progression of Human Malignant Gliomas.

Authors:  Zangbéwendé Guy Ouédraogo; Julian Biau; Jean-Louis Kemeny; Laurent Morel; Pierre Verrelle; Emmanuel Chautard
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

4.  Characterization of cis-regulatory elements conferring mercury-induced interleukin-4 gene expression in rat mast cells: a role for signal transducer and activator of transcription 6 and TATA box binding sites.

Authors:  Zonglin Wu; Alex Pearson; David Oliveira
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

5.  Purification and identification of the STAT5 protease in myeloid cells.

Authors:  Björn Schuster; Lisa Hendry; Helen Byers; Steven F Lynham; Malcolm A Ward; Susan John
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

6.  Direct effects of IL-4 on mast cells drive their intestinal expansion and increase susceptibility to anaphylaxis in a murine model of food allergy.

Authors:  O T Burton; A R Darling; J S Zhou; M Noval-Rivas; T G Jones; M F Gurish; T A Chatila; H C Oettgen
Journal:  Mucosal Immunol       Date:  2012-11-14       Impact factor: 7.313

7.  Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency.

Authors:  Chong Wang; Caixia Zhu; Fang Wei; Shujun Gao; Liming Zhang; Yuhong Li; Yanling Feng; Yin Tong; Jianqing Xu; Bin Wang; Zhenghong Yuan; Erle S Robertson; Qiliang Cai
Journal:  PLoS Pathog       Date:  2017-01-18       Impact factor: 6.823

8.  Tespa1 plays a role in the modulation of airway hyperreactivity through the IL-4/STAT6 pathway.

Authors:  Ruhui Yang; Guangli Wang; Lingyun Li; Hanjiang He; Mingzhu Zheng; Linrong Lu; Songquan Wu
Journal:  J Transl Med       Date:  2020-11-23       Impact factor: 5.531

9.  Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase.

Authors:  Caroline Schoenherr; Katharina Wohlan; Iris Dallmann; Andreas Pich; Jan Hegermann; Arnold Ganser; Denise Hilfiker-Kleiner; Olaf Heidenreich; Michaela Scherr; Matthias Eder
Journal:  PLoS One       Date:  2019-12-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.